ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

Kelly-Anne Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.